Schizophrenia and Psychoses

Latest

Schizophrenia Relapse Rate Lower With Injectable Versus Oral Antipsychotics

Schizophrenia Relapse Rate Lower With Injectable Versus Oral Antipsychotics

The risk for rehospitalization was 22% lower during treatment with long-acting injectable antipsychotic medications compared with treatment with equivalent oral formulations in the total cohort.

Schizophrenia Symptoms May Benefit From Specific Kind of Talk Therapy

Schizophrenia Symptoms May Benefit From Specific Kind of Talk Therapy

Schizophrenia patients may benefit from a a specific type of talk therapy, according to a new study from the University of Pennsylvania.

Concomitant Use of Antidepressants, Antipsychotics Linked to T2D Risk

Concomitant Use of Antidepressants, Antipsychotics Linked to T2D Risk

Concomitant SSRI/SNRI use was associated with an increased diabetes risk in AAP-treated young people.

Schizophrenia: Are There Any Effective Pharmacologic Combinations?

Schizophrenia: Are There Any Effective Pharmacologic Combinations?

There is currently no approved drug combination for treatment-resistant schizophrenia.

Cardiometabolic Outcomes in Schizophrenia Improved by Liraglutide

Cardiometabolic Outcomes in Schizophrenia Improved by Liraglutide

In patients with schizophrenia being treated with clozapine or olanzapine, liraglutide significantly improved glucose tolerance, body weight, and other cardiometabolic disturbances.

Schizophrenia Treatment Can Benefit From Electroconvulsive Therapy

Schizophrenia Treatment Can Benefit From Electroconvulsive Therapy

Electroconvulsive therapy can be a clinically effective treatment for patients with severe forms of schizophrenia.

Late Teen Emotional Stability Inversely Tied to Mental Illness

Late Teen Emotional Stability Inversely Tied to Mental Illness

Emotional stability assessed in late adolescence is inversely associated with serious mental illness.

Valbenazine Effective for Tardive Dyskinesia in Schizophrenia

Valbenazine Effective for Tardive Dyskinesia in Schizophrenia

Long-term valbenazine may be beneficial in managing tardive dyskinesia.

BMI In Schizophrenia Patients Associated With C-reactive Protein

BMI In Schizophrenia Patients Associated With C-reactive Protein

Body mass index in patients with schizophrenia is linked to C-reactive protein.

Metabolic, Endocrine Profiles Examined in Long-term Schizophrenia Therapy

Metabolic, Endocrine Profiles Examined in Long-term Schizophrenia Therapy

Schizophrenia outpatients were examined in this 52-week open-label extension trial.

Sign Up for Free e-newsletters